scispace - formally typeset
Open AccessJournal ArticleDOI

The endocannabinoid system as a target for novel anxiolytic drugs

Reads0
Chats0
TLDR
Evidence that cannabidiol (CBD), while representing a less specific pharmacological approach, may be another way to modulate eCBs and interacting neurotransmitter systems to alleviate anxiety is reviewed.
About
This article is published in Neuroscience & Biobehavioral Reviews.The article was published on 2017-05-01 and is currently open access. It has received 164 citations till now. The article focuses on the topics: Anxiolytic & Endocannabinoid system.

read more

Citations
More filters
Journal ArticleDOI

Natural Products from Cyanobacteria: Focus on Beneficial Activities.

TL;DR: The present review focuses on the beneficial activities of cyanobacterial molecules described so far and selected and specifically described 47 molecule families according to their respective bioactivities and their potential uses in pharmacology, cosmetology, agriculture, or other specific fields of interest.
Journal ArticleDOI

Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder.

TL;DR: It is proposed that a state of endocannabinoid deficiency could represent a stress susceptibility endophenotype predisposing to the development of trauma- related psychopathology and provide biologically plausible support for the self-medication hypotheses used to explain high rates of cannabis use in patients with trauma-related disorders.
Journal ArticleDOI

Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science

TL;DR: Knowledge of the individual medicinal properties of the cannabinoids, terpenes, and flavonoids is necessary to cross‐breed strains to obtain optimal standardized synergistic compositions, which will enable targeting individual symptoms and/or diseases.
Journal ArticleDOI

Animal models of PTSD: a challenge to be met

TL;DR: It is suggested that with an appropriate shift of practice, animal models are not only a valuable tool to enhance the authors' understanding of fear and memory processes, but could serve as effective platforms for understanding PTSD, for PTSD drug development and drug testing.
Journal ArticleDOI

Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders.

TL;DR: Compounds such as D-cycloserine, MDMA, L-DOPA and cannabinoids have shown efficacy in enhancing fear-extinction learning in humans, and are investigated in clinical trials as an augmentative strategy for speeding up and enhancing the long-term effectiveness of exposure-based psychotherapy.
References
More filters
Journal ArticleDOI

Posttraumatic stress disorder in the National Comorbidity Survey.

TL;DR: Progress in estimating age-at-onset distributions, cohort effects, and the conditional probabilities of PTSD from different types of trauma will require future epidemiologic studies to assess PTSD for all lifetime traumas rather than for only a small number of retrospectively reported "most serious" traumAs.
Journal ArticleDOI

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

TL;DR: It is shown that the vasodilator response to anandamide in isolated arteries is capsaicin-sensitive and accompanied by release of calcitonin-gene-related peptide (CGRP), which indicates that the vanilloid receptor may be another molecular target for endogenousAnandamide, besides cannabinoid receptors, in the nervous and cardiovascular systems.
Journal ArticleDOI

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

TL;DR: It is shown that oleamide hydrolase may serve as the general inactivating enzyme for a growing family of bioactive signalling molecules, the fatty-acid amides6–8, and the structure and sleep-inducing properties of cis-9-octadecenamide, a lipid isolated from the cerebrospinal fluid of sleep-deprived cats are reported.
PatentDOI

Modulation of anxiety through blockade of anandamide hydrolysis

TL;DR: In this paper, Fatty acid amide hydrolase inhibitors of the Formula (I) are provided, wherein X is NH, CH2, O, or S, Q is O or S; Z is O/N; R is an aromatic moiety selected from the group consisting of substituted or unsubstituted aryl; substituted or unweighted biphenylyl, substituted or naphthyl, and substituted or unsaturated phenyl.
Related Papers (5)